{
    "clinical_study": {
        "@rank": "132835", 
        "arm_group": {
            "arm_group_label": "lung cancer patients", 
            "description": "Non Small Cell Lung Cancer, Small Cell Lung Cancer"
        }, 
        "brief_summary": {
            "textblock": "The study examines the physical capacity of lung cancer patients assessed with the six\n      minute walk test and handgrip strength. Demographic and selfreported exercise behavior is\n      registered to explore correlations to functional and physical capacity.\n\n      Assessments are made before first chemotherapy cycle and after fourth chemotherapy cycle, an\n      expected average of 12 weeks between first and second assessment."
        }, 
        "brief_title": "Value of Physical Capacity Tests in Lung Cancer", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Non Small Cell Lung Cancer", 
            "Small Cell Lung Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Non-Small-Cell Lung", 
                "Lung Neoplasms", 
                "Small Cell Lung Carcinoma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Non small cell lung cancer stage I-IV\n\n          -  Small cell lung cancer\n\n          -  Patients >18 years\n\n          -  WHO performance status 0-2\n\n          -  undergoing chemotherapy\n\n        Exclusion Criteria:\n\n          -  unstable angina during the previous month\n\n          -  myocardial infarction diagnosed within the last month\n\n          -  not approval for physical activity by primary oncologist\n\n          -  inability to provide informed consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Non Small Cell Lung Cancer Stage Small Cell Lung Cancer"
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01943578", 
            "org_study_id": "2007-58-0015-30-1059"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 16, 2013", 
        "link": {
            "url": "http://www.ucsf.dk/"
        }, 
        "location": {
            "contact": {
                "email": "seppo.langer@regionh.dk", 
                "last_name": "Seppo Langer, Phd", 
                "phone": "004535458680"
            }, 
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "zip": "2200"
                }, 
                "name": "University Hospital of Copenhagen"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_groups": "1", 
        "official_title": "Prospective Observational Cohort Study of the Value of the Six Minute Walk Test and Handgrip Strength in Lung Cancer Patients Undergoing Chemotherapy", 
        "other_outcome": {
            "description": "Patient reported outcome", 
            "measure": "FACT-L", 
            "safety_issue": "No", 
            "time_frame": "Before first chemotherapy and after fourth cycle of chemotherapy, an expected average of 12 weeks between first and second assessment."
        }, 
        "overall_contact": {
            "email": "morten.quist@regionh.dk", 
            "last_name": "Morten Quist, M.Sc", 
            "phone": "004523467919"
        }, 
        "overall_contact_backup": {
            "email": "eik_bjerre@hotmail.com", 
            "last_name": "Eik Bjerre, B.Sc", 
            "phone": "004522749076"
        }, 
        "overall_official": {
            "affiliation": "University Hospital of Copenhagen, Rigshospitalet", 
            "last_name": "Seppo Langer, Phd.", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Dataprotection Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Prognostic value of the six minute walk and handgrip strength on mortality", 
            "measure": "Mortality - Survival time", 
            "safety_issue": "No", 
            "time_frame": "time from first chemotherapy treatment to death, assessed after 30 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01943578"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "Morten Quist", 
            "investigator_title": "phd student", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Hand grip strength", 
                "safety_issue": "No", 
                "time_frame": "before first chemotherapy and after fourth cycle of chemotherapy, an expected average of 12 weeks between first and second assessment."
            }, 
            {
                "measure": "Self reported exercise behavior", 
                "safety_issue": "No", 
                "time_frame": "before first chemotherapy and after fourth cycle of chemotherapy, an expected average of 12 weeks between first and second assessment."
            }, 
            {
                "measure": "Six minute walk test", 
                "safety_issue": "No", 
                "time_frame": "Before first and after fourth chemotheraphy cycle, an expected average of 12 weeks between first and second assessment."
            }
        ], 
        "source": "Rigshospitalet, Denmark", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rigshospitalet, Denmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}